GENESPIRE

genespire-logo

Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases, particularly primary immunodeficiencies and inherited metabolic diseases.

#SimilarOrganizations #People #Financial #Event #Website #More

GENESPIRE

Industry:
Biotechnology Life Science

Founded:
2020-03-01

Address:
Milan, Lombardia, Italy

Country:
Italy

Website Url:
http://www.genespire.com

Total Employee:
1+

Status:
Active

Contact:
39 02 83991300

Email Addresses:
[email protected]

Total Funding:
16 M EUR

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Mobile Non Scaleable Content Nginx


Similar Organizations

affinia-therapeutics-logo

Affinia Therapeutics

Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with devastating diseases.

enliven-therapeutics-logo

Enliven Therapeutics

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

new-amsterdam-pharma-logo

New Amsterdam Pharma

New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.


Current Advisors List

graziano-seghezzi_image

Graziano Seghezzi Board Member @ Genespire
Board_member
2020-04-29

jörn-aldag_image

Jörn Aldag Chairman Of The Board @ Genespire
Board_member
2020-04-01

lucia-faccio_image

Lucia Faccio Board Member @ Genespire
Board_member
2019-04-29

Current Employees Featured

julia-berretta_image

Julia Berretta
Julia Berretta Chief Executive Officer @ Genespire
Chief Executive Officer

philippe-mauberna_image

Philippe Mauberna
Philippe Mauberna Chief Financial Officer @ Genespire
Chief Financial Officer

alessio-cantore_image

Alessio Cantore
Alessio Cantore Co-Founder & Scientific @ Genespire
Co-Founder & Scientific

sabah-sallah_image

Sabah Sallah
Sabah Sallah Chief Medical Officer @ Genespire
Chief Medical Officer
2022-01-01

julianne-smith_image

Julianne Smith
Julianne Smith Chief Development Officer @ Genespire
Chief Development Officer

luigi-naldini_image

Luigi Naldini
Luigi Naldini Co-Founder, Scientific & Board Member @ Genespire
Co-Founder, Scientific & Board Member

Founder


alessio-cantore_image

Alessio Cantore

luigi-naldini_image

Luigi Naldini

Investors List

sofinnova-partners_image

Sofinnova Partners

Sofinnova Partners investment in Series A - Genespire

Key Employee Changes

Date New article
2022-07-07 Genespire appoints Dr. Sabah Sallah as Chief Medical Officer

Official Site Inspections

http://www.genespire.com

  • Host name: carnage.evtel.com
  • IP address: 18.156.43.197
  • Location: Frankfurt am Main Germany
  • Latitude: 50.1188
  • Longitude: 8.6843
  • Timezone: Europe/Berlin
  • Postal: 60313

Loading ...

More informations about "Genespire"

The company - Genespire

Genespire is led by an experienced and international management team with experience from renowned biotech companies and world-class …See details»

Genespire - Crunchbase Company Profile & Funding

Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases.See details»

Genespire - LinkedIn

Genespire is a biotechnology company focused on the development of durable and transformative gene therapies for patients affected by genetic diseases, particularly primary …See details»

Genespire 2025 Company Profile: Valuation, Funding

Information on valuation, funding, cap tables, investors, and executives for Genespire. Use the PitchBook Platform to explore the full profile.See details»

Genespire - Funding, Financials, Valuation & Investors

Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases.See details»

Genespire - Milano, Italy

Oct 1, 2024 Genespire is a biotechnology company focused on the development of durable and transformative gene therapies for patients affected by genetic diseases, particularly primary …See details»

Genespire s.r.l. - VentureRadar

"At Genespire we develop first-in-class gene therapies with the aim of curing people affected by severe diseases. Our therapies are based on proprietary advanced lentiviral vector platforms …See details»

Our science - Genespire

Our candidate products respond to actual unmet medical needs and are designed to enhance both the safety and efficacy profile of gene therapy. Genespire Srl Genespire’s mission is to …See details»

Genespire - Contacts, Employees, Board Members, Advisors

Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases.See details»

Genespire | The Pharmaletter

Sep 25, 2024 Genespire is developing gene therapies based on immune shielded lentiviral vectors (ISLVs) that are designed to be used intravenously and allow the life-long production …See details»

Genespire Company Profile - Office Locations, Competitors ... - Craft

Genespire has 5 employees at their 1 location and $17.34 m in total funding,. See insights on Genespire including office locations, competitors, revenue, financials, executives, subsidiaries …See details»

Genespire - Sofinnova Partners

Sep 11, 2024 Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases, particularly primary …See details»

Genespire | Biotech Careers

Genespire’s mission is to enable children affected by genetic diseases to benefit from the life-changing potential of gene therapy. Business Areas: Cell and Gene TherapySee details»

Genespire Company Information - Funding, Investors, and More

Get information on funding, investors, industries, and more for Genespire. See Genespire company profile and funding data.See details»

Overview - Genespire

Genespire has generated a novel proprietary class of lentiviral vectors, the Immune Shielded Lentiviral Vectors (ISLVs), which are masked from the patient’s immune system.See details»

Genespire raises €46.6 million (~$52 million) in a Series ... - BioSpace

Sep 25, 2024 About Genespire Genespire is a biotechnology company, developing off-the-shelf gene therapies based on immune shielded lentiviral vectors (ISLVs) for pediatric patients …See details»

Genespire: boosting gene therapy efficiency, efficacy

May 11, 2021 San Raffaele gene therapy spinout Genespire is deploying gene editing and delivery platforms to develop therapies for primary immunodeficiencies and inherited metabolic …See details»

Genespire raises $52m in Series B to trial paediatric gene therapy

Sep 25, 2024 The funds will advance Genespire’s gene therapy for methylmalonic acidemia, a group of rare metabolic disorders, to Phase I/II trials.See details»

Programs - Genespire

Genespire’s ISLV-based gene therapy presents a distinct alternative, offering a one-time treatment option accessible to pediatric patients who represent the majority of MMA patients.See details»

DNA organization offers clues for advancing stem cell therapy

3 days ago DNA organization offers clues for advancing stem cell therapy UC Riverside-led study could help advance treatments for injuries, aging, and diseasesSee details»

linkstock.net © 2022. All rights reserved